Docket Management
Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5
Comment Number: EC -2
Accepted - Volume 3
Comment Record
Commentor
Mrs. Janis Sherwood
Date/Time
2002-10-31 09:57:26
Organization
Terre Pharmaceuticals
Category
Individual
Comments for FDA General
Questions
1. General Comments
The proposed idea to test children ages 2-5 is a very bad idea. I do not think it should be done.
EC -2